Toggle Main Menu Toggle Search

Open Access padlockePrints

Prevalence, management, and outcomes of patients with coagulopathy after acute nonvariceal upper gastrointestinal bleeding in the United Kingdom

Lookup NU author(s): Dr Sarah Hearnshaw

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

BACKGROUND: Coagulopathy after major hemorrhage has been found to be an independent risk factor for mortality after traumatic bleeding. It is unclear whether similar associations are present in other causes of major hemorrhage. We describe the prevalence, use of plasma, and outcomes of patients with coagulopathy after acute nonvariceal upper gastrointestinal bleeding (NVUGIB). STUDY DESIGN AND METHODS: This study was a multicenter UK national audit. Data were collected prospectively on consecutive admissions with upper gastrointestinal bleeding over a 2-month period to 212 UK hospitals. Coagulopathy was defined as an international normalized ratio (INR)of at least 1.5. Logistic regression was used to examine the relationship between coagulopathy and patient-related outcome measures of mortality, rebleeding, and need for surgery and/or radiologic intervention. RESULTS: A total of 4478 patients were included in the study. Coagulopathy was present in 16.4% (444/2709) of patients in whom an INR was recorded. Patients with coagulopathy were more likely to present with hemodynamic shock (45% vs. 36%), have a higher clinical Rockall score (4 vs. 2), receive red blood cell transfusion (79% vs. 48%) and have high-risk stigmata of hemorrhage at endoscopy (34% vs. 25%). After adjustment for confounders the presence of a coagulopathy was associated with a fivefold increased in the odds of mortality (odds ratio, 5.63; 95% confidence interval, 3.09-10.27; p<0.001). Only 35% of patients with coagulopathy received fresh-frozen plasma transfusion. CONCLUSIONS: Coagulopathy was prevalent in 16% of patients after NVUGIB and independently associated with more than a fivefold increase in the odds of in-hospital mortality. Wide variation in plasma use exists indicates clinical uncertainty regarding optimal practice.


Publication metadata

Author(s): Jairath V, Kahan BC, Stanworth SJ, Logan RFA, Hearnshaw SA, Travis SPL, Palmer KR, Murphy MF

Publication type: Article

Publication status: Published

Journal: Transfusion

Year: 2013

Volume: 53

Issue: 5

Pages: 1069-1076

Print publication date: 01/05/2013

Online publication date: 15/08/2012

Acceptance date: 02/07/2012

ISSN (print): 0041-1132

ISSN (electronic): 1537-2995

Publisher: Wiley-Blackwell

URL: http://dx.doi.org/10.1111/j.1537-2995.2012.03849.x

DOI: 10.1111/j.1537-2995.2012.03849.x


Altmetrics

Altmetrics provided by Altmetric


Share